A 72-year-old woman with known paroxysmal atrial fibrillation presents with recurrent episodes of palpitations and syncope. Standard 12-lead ECG and transthoracic echocardiography are normal. The patient is on metoprolol but continues to have breakthrough episodes. Which investigation is most appropriate to identify the mechanism and guide catheter ablation?

## Electrophysiology Study in Atrial Fibrillation ### Clinical Context: When EP Study is Indicated This patient has **symptomatic, drug-refractory paroxysmal AF** with syncope and normal structural cardiac findings. The next step is electrophysiology (EP) study to: 1. Confirm the diagnosis and mechanism of AF 2. Identify arrhythmogenic foci (typically pulmonary veins in paroxysmal AF) 3. Guide catheter ablation strategy 4. Assess for additional arrhythmias (e.g., accessory pathways, AV nodal reentry) **Key Point:** Electrophysiology study is the investigation of choice for patients with recurrent symptomatic AF refractory to antiarrhythmic drugs who are candidates for catheter ablation [cite:Harrison 21e Ch 226]. ### Role of EP Study in AF Management **High-Yield:** EP study serves **three critical functions**: 1. **Diagnostic confirmation** — directly visualizes atrial activation patterns and confirms AF mechanism 2. **Substrate mapping** — identifies ectopic foci and reentrant circuits (pulmonary veins are the source in ~90% of paroxysmal AF) 3. **Therapeutic planning** — guides ablation target selection and predicts success ### Comparison of Diagnostic Modalities | Investigation | Sensitivity for AF | Specificity | Therapeutic Capability | Indication | | --- | --- | --- | --- | --- | | **12-lead ECG** | High during AF | High | None | Confirms AF during episode | | **Holter (24 hrs)** | Moderate | High | None | Paroxysmal AF; symptom correlation | | **Event monitor (30 days)** | Moderate–High | High | None | Intermittent symptoms; AF burden | | **Stress test** | Low–Moderate | Moderate | None | Exercise-induced AF; CAD screening | | **EP study** | 100% (intracardiac) | 100% | **Yes — ablation** | Drug-refractory AF; ablation candidate | **Clinical Pearl:** In this patient, Holter and event monitors would likely capture AF episodes and quantify burden, but they do **not** identify the mechanism or guide ablation. Since she is symptomatic and drug-refractory, she is a candidate for catheter ablation, which requires EP study for mapping. ### Why EP Study is Superior in This Scenario ```mermaid flowchart TD A[Symptomatic paroxysmal AF]:::outcome A --> B[Structural echo normal?]:::decision B -->|Yes| C[Drug-refractory?]:::decision C -->|Yes| D[Candidate for ablation?]:::decision D -->|Yes| E[EP Study with mapping]:::action E --> F[Identify PV foci or substrate]:::outcome F --> G[Catheter ablation]:::action G --> H[Symptom resolution]:::outcome C -->|No| I[Continue medical therapy]:::action D -->|No| I ``` **Mnemonic:** **EPABL** — when EP study is indicated in AF: - **E**pisodes symptomatic and **E**xcessive - **P**aroxysmal or persistent - **A**blation candidate (structurally normal heart, motivated) - **B**reakthrough despite **B**eta-blockers/antiarrhythmics - **L**eft atrium normal size (better ablation outcomes) ### Diagnostic Yield of EP Study in Paroxysmal AF - **Pulmonary vein triggers** identified in ~90% of paroxysmal AF cases - **Non-PV foci** (superior vena cava, coronary sinus, left atrial appendage) in ~10% - **Successful ablation** achieves AF-free survival in 70–80% at 1 year for paroxysmal AF **Warning:** Do NOT confuse EP study with **electrogram recording alone**. EP study includes programmed electrical stimulation, which can induce AF and assess inducibility — essential for ablation planning.